PUMA BIOTECHNOLOGYPBYI
那斯達克 · USD
8.91
+0.79
(+9.73%)
收盤 08/08 03:59 (UTC+8)
08/08 03:59 (UTC+8)
PUMA BIOTECHNOLOGYPBYI
8.91
+0.79
(+9.73%)
財務數據
損益表
- 0.44
- 0.47
- 0.81
- 0.59
- 0.46
- 0.52
- 0.54
- 0.75
- 0.45
- 0.57
- -39.36
- 7.58
- 71.06
- -26.65
- -22.12
- 13.97
- 3.89
- 38.51
- -40.61
- 26.08
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 56,502 | 44,814 | 75,453 | 54,475 | 52,436 | 46,007 | 59,077 | 80,542 | 47,083 | 43,766 |
營業成本 | - | 10,424 | 23,127 | 12,173 | 12,301 | 10,556 | 13,921 | 29,097 | 10,658 | 10,728 |
營業毛利 | - | 34,390 | 52,326 | 42,302 | 40,135 | 35,451 | 45,156 | 51,445 | 36,425 | 33,038 |
營業費用 | - | 38,218 | 35,220 | 32,729 | 33,499 | - | 31,791 | 29,366 | 38,604 | 35,337 |
研發費用 | - | 19,795 | 16,841 | 15,912 | 15,452 | 13,863 | 15,169 | 12,547 | 13,632 | 13,587 |
推銷及管理費用 | - | 18,423 | 18,379 | 16,817 | 18,047 | 17,604 | 16,622 | 16,819 | 24,972 | 21,750 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 7,585 | -3,828 | 17,106 | 9,573 | 6,636 | 3,984 | 13,365 | 22,079 | -2,179 | -2,299 |
其他收入及費用 | - | 1,132 | 1,120 | 1,159 | 1,366 | 1,460 | 1,494 | 1,629 | 1,400 | 1,063 |
利息費用 | - | 731 | 1,119 | 1,489 | 1,837 | 2,177 | 2,621 | 3,100 | 3,372 | 3,359 |
稅前純益 | 8,245 | -3,427 | 17,107 | 9,243 | 6,165 | 3,267 | 12,238 | 20,608 | -4,151 | -4,595 |
所得稅 | - | 326 | 3,669 | 399 | 310 | 293 | -7,067 | 291 | 378 | 220 |
稅後純益 | 8,189 | -3,753 | 13,438 | 8,844 | 5,855 | 2,974 | 19,305 | 20,317 | -4,529 | -4,815 |
基本每股稅後盈餘(元) | 0.16 | -0.07 | 0.27 | 0.18 | 0.12 | 0.06 | 0.39 | 0.41 | -0.09 | -0.10 |
稀釋每股稅後盈餘(元) | 0.16 | -0.07 | 0.26 | 0.17 | 0.12 | 0.06 | 0.40 | 0.41 | -0.09 | -0.10 |
基本平均股數(千股) | 50939.00 | 50845.00 | 50339.00 | 50339.00 | 49700.00 | 49595.00 | 49095.00 | 49008.00 | 48292.00 | 48189.00 |
稀釋平均股數(千股) | 52596.00 | 50845.00 | 51521.00 | 50929.00 | 50144.00 | 49906.00 | 49408.00 | 49173.00 | 48292.00 | 48189.00 |
還原基本每股稅後盈餘(元) | 0.16 | -0.07 | 0.27 | 0.18 | 0.12 | 0.06 | 0.39 | 0.41 | -0.09 | -0.10 |
還原稀釋每股稅後盈餘(元) | 0.16 | -0.07 | 0.26 | 0.17 | 0.12 | 0.06 | 0.40 | 0.41 | -0.09 | -0.10 |
還原基本平均股數(千股) | 50,939 | 50,845 | 50,339 | 50,339 | 49,700 | 49,595 | 49,095 | 49,008 | 48,292 | 48,189 |
還原稀釋平均股數(千股) | 52,596 | 50,845 | 51,521 | 50,929 | 50,144 | 49,906 | 49,408 | 49,173 | 48,292 | 48,189 |
EBITDA(千元) | 8,189 | -112 | 20,883 | 13,454 | 10,765 | 8,240 | 17,700 | 26,586 | 2,129 | 1,661 |